At the time of writing, Hookipa Pharma Inc [HOOK] stock is trading at $1.62, up 6.58%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HOOK shares have gain 11.72% over the last week, with a monthly amount glided 107.69%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hookipa Pharma Inc [NASDAQ: HOOK] stock has seen the most recent analyst activity on December 20, 2024, when RBC Capital Mkts downgraded its rating to a Sector Perform and also revised its price target to $2 from $48. Previously, RBC Capital Mkts reaffirmed its Outperform rating on November 15, 2024, and dropped its price target to $48. On December 02, 2022, downgrade downgraded it’s rating to Underperform but maintained its price target of $0.50 on the stock. BofA Securities downgraded its rating to a Underperform. Morgan Stanley downgraded its rating to a Equal-Weight but $6 remained the price target by the analyst firm on November 12, 2021. Morgan Stanley started tracking with a Overweight rating for this stock on April 08, 2021, and assigned it a price target of $19. In a note dated November 03, 2020, Truist initiated an Buy rating and provided a target price of $21 on this stock.
For the past year, the stock price of Hookipa Pharma Inc fluctuated between $0.72 and $105.00. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Hookipa Pharma Inc [NASDAQ: HOOK] shares were valued at $1.62 at the most recent close of the market. An investor can expect a potential return of 85.19% based on the average HOOK price forecast.
Analyzing the HOOK fundamentals
According to Hookipa Pharma Inc [NASDAQ:HOOK], the company’s sales were 9.35M for trailing twelve months, which represents an -94.52% plunge. Gross Profit Margin for this corporation currently stands at 0.9% with Operating Profit Margin at -10.95%, Pretax Profit Margin comes in at -9.99%, and Net Profit Margin reading is -9.98%. To continue investigating profitability, this company’s Return on Assets is posted at -1.2, Equity is -1.21 and Total Capital is -1.8. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4767 points at the first support level, and at 1.3333 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7567, and for the 2nd resistance point, it is at 1.8933.
Ratios To Look Out For
It is important to note that Hookipa Pharma Inc [NASDAQ:HOOK] has a current ratio of 3.61. Also, the Quick Ratio is 3.61, while the Cash Ratio stands at 2.42. Considering the valuation of this stock, the price to sales ratio is 2.11, the price to book ratio is 0.57.
